Analysts have been eager to weigh in on the Financial sector with new ratings on Lemonade (LMND) and GoHealth (GOCO).
Lemonade (LMND)
Barclays analyst Ross Sandler maintained a Hold rating on Lemonade on November 11 and set a price target of $58.00. The company’s shares closed last Thursday at $56.00.
According to TipRanks.com, Sandler is a 5-star analyst with an average return of 15.0% and a 68.7% success rate. Sandler covers the Technology sector, focusing on stocks such as Spotify Technology SA, Uber Technologies, and Alphabet Class A.
Lemonade has an analyst consensus of Hold, with a price target consensus of $63.75, implying a 4.6% upside from current levels. In a report issued on November 11, Oppenheimer also maintained a Hold rating on the stock.
See today’s analyst top recommended stocks >>
GoHealth (GOCO)
Barclays analyst Steven Valiquette maintained a Buy rating on GoHealth on November 11 and set a price target of $18.00. The company’s shares closed last Thursday at $11.11, close to its 52-week low of $10.02.
According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 2.9% and a 55.9% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as American Renal Associates Holdings, Patterson Companies, and AmerisourceBergen.
Currently, the analyst consensus on GoHealth is a Strong Buy with an average price target of $19.75, which is a 66.7% upside from current levels. In a report issued on November 11, Raymond James also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
